SoftOx Solutions (Part 1)

[polsmannen]

Ok, ja da er jeg med, tenkte/håpte nok bare litt større enn det Norske…

[Hardox]

Noen som har sett produktene på Meny eller Bunnpris og muligens apotek via Aeris? Hadde vært greit å vite om den avtalen med Norgesgruppen var i rute

[pips]

Doblet min investering i Softox i går. Blir overrasket hvis ikke Soft kommer med noe kursdrivende informasjon i forbindelse med rep emien.

[stkongsv]

Sjekk forsiden på Røde Kors:
www.rodekorsforstehjelp.no

God eksponering av Antivir/Softox der iallefall…

[TekBot]

SoftOx Solutions AS: National Prospectus registered and commencement of subscription period in the subsequent offering

Reference is made to the stock exchange announcements from SoftOx Solutions AS (the “Company”) on 16 December 2020 regarding the successful completion of a private placement and the contemplated repair issue to be carried out.
The subsequent offering was approved by the Company’s extraordinary general meeting on 4 January 2021 (the “Subsequent Offering”).

…

Vis børsmeldingen

For the purposes of the Subsequent Offering, the Company has prepared a national prospectus (the “Prospectus”). The Prospectus has today been registered in the Norwegian Register of Business Enterprises (Nw: Foretaksregisteret). The Prospectus will be published on 17 February 2021 prior to the start of the Subscription Period, and can be obtained electronically by downloading it from www.soft-ox.com, www.sb1markets.no, or by contacting the Company or SpareBank 1 Markets AS (the “Manager”).

The Subsequent Offering comprises an offer of up to 181,818 new shares in the Company (the “Offer Shares”) at an offer price of NOK 55 per Offer Share, which equals the subscription price in the Private Placement announced by the Company on 16 December 2020. Total gross proceeds will amount to approximately NOK 9,999,990 million if all the Offer Shares are allocated.

The Company will, subject to applicable securities laws, grant non-transferable subscription rights to subscribe for Offer Shares to shareholders in the Company as of close of trading on 16 December 2020 as registered in the Norwegian Central Securities Depository (the “VPS”) on 18 December 2020 (the “Record Date”) who were not allocated shares in the Private Placement and who are not resident in a jurisdiction where such offering would be unlawful, or for jurisdictions other than Norway, would require any filing, registration or similar action (the “Eligible Shareholders”). Eligible Shareholders will be granted 0.0279 Subscription Rights for each share held. Each Subscription Right will give the right to subscribe for one Offer Share. Over-subscription and subscription without Subscription Rights will be permitted.

The subscription period in the Subsequent Offering commences on 17 February 2021 at 09:00 hours and will expire on 3 March 2021 at 16:30 hours CET (the “Subscription Period”).

In order to subscribe for shares, the Manager must receive a complete and duly signed subscription form within the end of the Subscription Period. Further instructions regarding the subscription procedure is available in the Prospectus. Subscription Rights not used to subscribe for Offer Shares prior to 16:30 hours on 3 March 2021 will have no value and will lapse without compensation to the holder.

Notifications of allocated Offer Shares and the corresponding subscription amount to be paid by each subscriber are expected to be distributed on or about 4 March 2021.

The payment for Offer Shares allocated to a subscriber falls due on 8 March 2021 (the “Payment Date”). Delivery of the Offer Shares to investors’ VPS accounts is expected to take place on or about 15 March 2021.

In addition to the Subsequent Offering, the Board of Directors has resolved that up to 181,818 new shares will, subject to applicable prospectus requirements and available exemptions, be offered to eligible employees, the members of the board of directors and certain invited hired external consultants of the Company at the same subscription price as in the Private Placement and the Subsequent Offering. The shares offered to employees will be issued by the board of directors under the authorisation to issue shares granted by the general meeting on 4 January 2021.

SpareBank 1 Markets AS are acting as Manager in connection with the Subsequent Offering. Advokatfirmaet Wiersholm AS acts as legal advisor to as the Company in connection with the Subsequent Offering.

For more information regarding the Subsequent Offering, please refer to the Prospectus available from 17 February 2021 on the Company’s website www.soft-ox.com.

For further information, please contact:
Geir Almås, CEO of SoftOx Solutions AS
Mail: ir@soft-ox.com
Mobile: +47 948 59 599

About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth, Oslo) is a Norwegian
MedTech company based in Oslo with the aim of helping to combat major threats to
human health, namely the emergence of antimicrobial resistance (AMR), biofilm
infections in chronic wounds and the spread of viruses. For more information on
SoftOx, visit www.soft-ox.com

Kilde

[anon80503862]

En rask desperat letesjekk senere ser jeg at det står at prospektet blir publisert i morgen

[Hardox]

Lurer på mange mail selskapet har fått om det allerede
Satser på de krydrer morgendagen med noe litt spennende da… 2 uker siden intensjonsavtalen…

[solskimm]

Tipper det kommer typ 1-2min før børsen åpner, eller i åpningstiden. Gud forby at de skal sende ut en melding så vi kan lese oss opp i ro og mak…

[polsmannen]

Blir en del mindre å få enn håpet 279stk ved 10k?

[h3nk1]

Så så, SoftOx trener oss opp med ett mål for øye.

[pips]

Sammenlignet med potten vi deler i rep emien vil jeg påstå at denne til ansatte med mer var temmelig stor. Likevel positivt at så mange rundt selskapet ønsker å være involvert.
“In addition to the Subsequent Offering, the Board of Directors has resolved that up to 181,818 new shares will, subject to applicable prospectus requirements and available exemptions, be offered to eligible employees, the members of the board of directors and certain invited hired external consultants of the Company at the same subscription price as in the Private Placement and the Subsequent Offering. The shares offered to employees will be issued by the board of directors under the authorisation to issue shares granted by the general meeting on 4 January 2021.”

[anon80503862]

@pips

Sammenlignet med potten vi deler i rep emien vil jeg påstå at denne til ansatte med mer var temmelig stor.

Enig.

Samtidig sier det noe om at her har folk som kjenner selskapet krevd å få kjøpe aksjer på 55kr. Noe som ikke nødvendigvis er dårlig nytt, selv om man blir utvannet.

[polsmannen]

Skal bli godt å få dette unnagjort nå slik at man kan begynne å løfte blikket å se lengre fremover

[pingvin]

Innsidehandel for 10 mill. er ikke akkurat dårlige nyheter.

[Hardox]

kanskje det kommer alle aksjonærer til gode å ha motiverte ansatte som er i samme båt som aksjonærene, og som fikk lov å tegne på 55 kr. Kan virke som de ikke har tenkt å ha emisjoner alt for ofte og at de inviterer med alle ansatte denne gang?

[anon80503862]

Dette må nesten ha jo ha kommet som en følge av internt press.

Grunnen til at jeg sier det er at det ikke var planlagt noen emisjon for de ansatte i desember (Q3, emisjon), eller januar (generalforsamling), men det kom informasjon om dette på Q4 rapporten.

Så min antagelse i hvert fall er at dette er noe enkelte ansatte har tatt opp at de ønsker mulighet til.

Det er også mye bedre enn opsjoner på kurs X, i mitt hode i hvert fall.

[Springer]

Det som er sikkert er at de kommer til å trenge penga. De flyr ut i økende tempo. Skuffet over at de ikke økte allokeringen til oss. Det kunne vi og de hatt nytte av.

[solskimm]

Jeg tror ikke Almås-brødrene gir ved dørene, begge er vel lastet til over pipa med aksjer - de ønsker nok så få aksjer som mulig for maks profitt.

[pingvin]

Det store forbruket av penger i Q4 gikk muligens til oppstarten av studie for sårskyll?

[M73102]

Spott on - dette er helt klart et press fra de ansatte, samt det er mye bedre at en gjør det på denne måten enn gjennom opsjoner. Dette er helt klart et relativt stort innsidekjøp!